Venture capital is finally chasing one of healthcare’s most boring problems: the referral handoff. Phoenix-based startup Basata just closed a $21 million Series A led by Basis Set Ventures, with Cowboy Ventures and the newly launched Sofeon firm joining in, according to TechCrunch AI. The round brings the two-year-old company’s total raised to $24.5 million and signals that investors see real money in fixing the administrative gap between primary care and specialists.
The problem is uglier than most outsiders realize. Specialty practices still receive most referrals by fax, and small admin teams routinely drown under hundreds or thousands of documents. Patients fall through the cracks not because doctors don’t want to see them, but because nobody can dig out from the intake pile fast enough to call them back.
What Basata actually does
Basata’s pitch is end-to-end automation of that intake mess:
- Reads incoming referral faxes and extracts the clinical info
- Dispatches an AI voice agent to call the patient and book the appointment
- Handles inbound patient calls 24/7 for things like prescription renewals
- Integrates directly with the EMR systems used by specific specialties
Co-founders Kaled Alhanafi (ex-Lyft, ex-Cruise) and Chetan Patel (a decade at Medtronic on cardiac devices) say the goal is for a patient to walk out of their primary care visit and have a specialist appointment booked before they reach the parking lot. Both founders told TechCrunch AI they hit the problem personally with family members who waited weeks, or never got a callback at all, after serious cardiac referrals.
Why this matters now
The US healthcare system runs on fax machines. That’s not a joke, it’s the operating reality. And the bottleneck isn’t a shortage of doctors so much as a shortage of administrative throughput. Every patient lost to an unanswered referral is revenue the practice never books and care a patient never gets.
Basata says it has processed referrals for roughly 500,000 patients to date, with 100,000 of those landing in the last month alone. That curve is what’s pulling capital into the category.
A crowded field, fast
Basata isn’t the only one chasing this. Per TechCrunch AI:
- Tennr (NYC, founded 2021): raised over $160 million from a16z, IVP, Lightspeed, and Google Ventures. Valued at $605 million. Heavy focus on document intelligence and proprietary medical-trained language models.
- Assort Health: backed by Lightspeed, focused on patient phone automation for specialty practices. Raised last year at a $750 million valuation.
Basata’s bet is specialization. The team picked cardiology first, then urology, and recently turned down a large deal in a specialty they hadn’t mapped deeply enough. Revenue is usage-based: per document processed, per call handled, no per-seat pricing. Cowboy Ventures founder Aileen Lee told TechCrunch AI that founder credibility actually matters here: “These doctors want to look you in the eye and know that they can count on you.”
What stands out
This is one of the cleanest examples of AI doing work that nobody enjoys, that nobody can hire fast enough to keep up with, and that has direct downstream consequences for patient health. The displacement question will eventually come for these admin roles, but the founders argue current staff are too buried to feel threatened. They’re drowning, and any rope helps.
The broader signal: investors have stopped treating “AI for healthcare admin” as a niche play. With three startups now collectively north of $1.4 billion in valuations, the fax-machine layer of US medicine is officially venture territory. Expect more entrants, more specialty-specific stacks, and pressure on hospital systems to actually integrate this stuff rather than buy it and shelve it.
Full reporting and founder quotes available at the original TechCrunch AI piece.